The term myo®brillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myo®brillar dissolution associated with accumulation of myo®brillar degradation products and ectopic expression of multiple proteins that include desmin, aBcrystallin (aBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and aBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 T 16 years (mean T SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electromyography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle ®bres are best identi®ed in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal ®bres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, aBC, dystrophin and b-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myo®brillar degeneration commencing at the Z-disk, accumulation of degraded ®lamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and aBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of aBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in de®ning the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.
Introduction
The light microscopic features of myo®brillar myopathy (MFM) were described in the 1970s and 1980s under such names as`myopathy with inclusion bodies' (Nakashima et al., 1970) ,`atypical myopathy with myo®brillar aggregates' (Kinoshita et al., 1975) ,`autosomal dominant cardiomyopathy with inclusions' (Clark et al., 1978) ,`cardioskeletal myopathy with intrasarcoplasmic dense granulo®lamentous material' (Fardeau et al., 1978) ,`autosomal dominant spheroid body myopathy' (Goebel et al., 1978) ,`myopathy with sarcoplasmic bodies and desmin ®laments' (Edstro Èm et al., 1980) ,`congenital myopathy with cytoplasmic bodies' (Wolburg et al., 1982) ,`congenital myopathy with Mallory body-like inclusions' (Fidzianska et al., 1983) and`familial cardiomyopathy with subsarcolemmal vermiform deposits' (Calderon et al., 1987) . Later, however, it became apparent that some authors described the same pathological reaction under different names; that more than one pathological alteration thought to be speci®c for a single disorder could be present in the same muscle specimen, or even in the same muscle ®bre; and that in each instance the pathological changes involve the Z-disks of the myo®bril. In 1980, Edstro Èm et al. (1980) noted that some inclusions or material around them reacted for desmin. This generated the names of desmin storage myopathy' (Horowitz and Schmalbruch, 1994) and later`desmin-related myopathies' (Goebel, 1997) . In 1996 and 1997, detailed immunocytochemical studies revealed that many proteins, not just desmin, accumulate in the abnormal ®bres, and prompted the use of the noncommittal term MFM (De Bleecker et al., 1996a; Nakano et al., 1997) .
Despite the morphological similarities, a wide spectrum of clinical ®ndings in MFM patients predicted genetic heterogeneity (Nakano et al., 1996; Amato et al., 1998; Engel, 1999) . Mutations in desmin (Goldfarb et al., 1998; MunozMa Ârmol et al., 1998; Sjo Èberg et al., 1999; Dalakas et al., 2000; Park et al., 2000; Sugawara et al., 2000; Goudeau et al., 2001; Schro Èder et al., 2003; Dagvadorj et al., 2003) and aBcrystallin (aBC; Vicart et al., 1998; Selcen and Engel, 2003) have now been uncovered in some MFM kinships; other MFM kinships were mapped to loci 2q24±31 (Asijee et al., 1990; Nicolao et al., 1999) , 10q22.3 (Melberg et al., 1999) and 12q (Wilhelmsen et al., 1996) , but no candidate genes or mutations were identi®ed at these loci.
We here describe our clinical, light microscopy, immunocytochemistry, electron microscopy and mutation analysis ®ndings in 63 MFM patients investigated at the Mayo Clinic.
The morphological data in seven of the 63 patients were reported previously (De Bleecker et al., 1996a; Nakano et al., 1996) . We also determine the frequency of patients carrying mutations in aBC and desmin, and search for mutations in syncoilin, which links desmin to the Z-disks (Howman et al., 2003) , and telethonin, a key Z-disk-associated protein (Kreienkamp et al., 1994) .
Patients and methods Patients
Sixty-three unrelated patients were diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. Histochemical and genetic studies were performed in muscle biopsy specimens of all patients. All studies were in accord with the guidelines of the Mayo Institutional Review Board.
Histochemistry
Flash-frozen muscle specimens were stored in liquid nitrogen until use. For conventional histochemical studies, 10 mm frozen sections were processed for haematoxylin±eosin (H&E), modi®ed Gomori trichrome, NADH dehydrogenase, succinate dehydrogenase, cytochrome c oxidase, adenosine triphosphatase (pre-incubation at pH 4.3, 4.6 and 9.4), acid phosphatase, periodic acid±Schiff (PAS), oil red O and nonspeci®c esterase. Amyloid deposits were visualized with the Congo red stain and rhodamine optics (Engel, 1994) .
Immunocytochemical studies
Cryostat sections 6±10 mm thick were immunostained with the primary antibodies listed in Table 1 . Consecutive sections in the series were stained with trichrome. An estimate of the proportion of abnormal ®bres immunoreacting for a given antigen was obtained by counting all ®bres harbouring abnormal deposits in four randomly selected low-power ®elds in a trichrome-stained section and then examining the corresponding ®elds in an immediately adjacent immunostained section. Non-speci®c binding was blocked by preincubation with phosphate-buffered saline, pH 7.4, containing 2% bovine serum albumin and 10% donkey or goat serum. Myotilin, desmin, aBC, dystrophin, plectin, cell division cycle (CDC) 2 kinase, prion protein, neural cell adhesion molecule (NCAM), gelsolin, ubiquitin, the N-and C-terminal and Kunitz protease inhibitor (KPI) domains of b-amyloid precursor protein (bAPP) and b-amyloid (Ab) protein were localized with the immunoperoxidase method using a biotinylated secondary antibody and the ABC kit (Vector Laboratories, Burlingame, CA). a-Actinin, nebulin and titin were visualized by immuno¯uorescence, with detection of the ®rst antibody with Cy3-labelled donkey anti-mouse IgG, or with biotinylated goat anti-mouse IgG followed bȳ uorescein isothiocyanate-or Cy3-labelled streptavidin. Filamentous actin was stained with rhodamine±phalloidin, following the manufacturer's instructions (Molecular Probes, Eugene, OR). Controls consisted of replacement of monoclonal antibodies with non-immune IgG of the same subclass and concentration as the primary antibody, and replacement of polyclonal antibodies by pooled non-immune IgG.
Electron microscopy
Muscle specimens were ®xed at rest length and processed for electron microscopy by standard methods (Engel,1994) .
Molecular genetic studies
DNA was isolated from muscle using the phenol/chloroform method (Sambrook and Russell, 2001) . mRNA was obtained using the Micro-FastTrack mRNA isolation kit (Invitrogen). First strand cDNA was prepared from mRNA by using random hexamer primers with the cDNA cycle kit (Invitrogen). Polymerase chain reaction (PCR) primers were designed to analyse all exons and their¯anking non-coding regions of desmin (DES), aBC (CRYAB), telethonin (TCAP) and syncoilin (SYNC) using published genomic sequences obtained from the human genome project. Published sequences of DES and CRYAB mRNA were used to design cDNA primers. PCR-ampli®ed fragments were puri®ed using the QIAquick 8 PCR Puri®cation Kit (Qiagen), and directly sequenced with an ABI377 DNA sequencer (Applied Biosystems) using¯uorescence-labelled dideoxy terminators. After identifying mutations in DES or CRYAB, allele-speci®c PCR was employed to screen for the identi®ed mutations in 200 normal alleles of 100 unrelated control subjects.
The entire coding region of DES was ampli®ed from normal human muscle mRNA using nested reverse transcription (RT)±PCR. The nested forward primer introduced the Kozak consensus sequence (5¢-CCACC-3¢) before the translational start site (Kozak, 1987) . The nested forward and reverse primers also carried EcoRI and HindIII recognition sites, respectively, at their 5¢ ends. The PCR product was then ligated into pEGFP-N1, a plasmid harbouring the gene encoding enhanced green¯uorescent protein (EGFP; Clontech), to attach EGFP to the C-terminal end of desmin. The mutated human desmin cDNA clones were obtained by introduction of the mutated oligonucleotides into pEGFP-DES using the Quik-Change Site Direct Mutagenesis kit (Stratagene). For each construct, the presence of the mutation and absence of unwanted artefacts were con®rmed by sequencing of the entire insert. Wild-type and mutant pEGFP-DES constructs were transfected into MCF7 cells derived from human breast adenocarcinoma cells, and into COS cells derived from green monkey kidney ®broblasts. Cells were transfected 24 h after plating using Fugene 6 (Roche) according to the manufacturer's instructions. At 48 h post-transfection, the cells were ®xed and analysed with a Zeiss epi¯uorescence microscope. Each transfection was repeated three times.
Results

Clinical characteristics of patients
Twenty-nine patients were women and 34 were men. The age of onset varied from 7 to 77 years (mean, 54 years; median 55 years) but only one patient presented before the age of 10 years, and only three before the age of 20 years. The age at diagnosis ranged from 21 to 82 years (mean, 62 years, median 64 years). Sixteen patients had evidence for autosomal dominant inheritance. Five patients had similarly affected family members, siblings or cousins, but the pattern of inheritance could not be determined with con®dence.
Symptoms elicited at the time of diagnosis consisted of slowly progressive weakness, 58; paresthesias, 10; muscle wasting, nine; muscle stiffness, aching or cramps, eight; dyspnoea, eight; dysphagia, four; head drop due to isolated neck extensor weakness, one; and palpitation, one.
Examination at the time of diagnosis revealed muscle weakness in all patients. The distribution of weakness was determined in 56 patients. In 41, the weakness involved both proximal and distal muscles; in 16 the weakness was equal proximally and distally; and in 16 it was greater distally than proximally. In 13 patients, the weakness was only proximal, and in two it was only distal. In seven patients, the weakness was asymmetric in distribution. Four patients had facial as well as limb weakness. None of the patients presented with a scapuloperoneal pattern of weakness. Ten patients had conspicuous muscle atrophy. One patient had elbow, wrist and hip contractures. Two patients had profound distal sensory de®cits.
Ten patients had cardiomyopathy at the time of diagnosis. Two of these patients had signs of congestive heart failure and arrhythmia; three had signs of congestive heart failure without arrhythmia; four had arrhythmia without congestive failure; and one patient had pre-symptomatic dilated cardiomyopathy discovered when the muscle biopsy ®ndings of MFM prompted an echocardiographic examination. Two of the 10 patients with cardiomyopathy had a dominantly inherited mutation in desmin. Ten other patients had miscellaneous electrocardiographic abnormalities compatible with cardiomyopathy (conduction block, prolonged QT interval, intermittent atrial ®brillation, unusual depolarization abnormality and premature ventricular complexes). Two of these patients had a mutation in desmin; in one case, the mutation was sporadic, in the other it was dominantly inherited. None of the 20 patients with cardiac abnormalities had mutations in aBC.
The serum creatine kinase (CK) level was normal in 23 patients, <7-fold above the upper normal limit in 30, and not determined in 10.
EMG studies were obtained in 57 patients. Myopathic motor unit potentials (MUPs) were recorded in 31, and both myogenic and high-amplitude long-duration MUPs in 19. Abnormal electrical irritability, consisting of ®brillation potentials, positive sharp waves and complex repetitive discharges, was present in 30 patients; 15 of these also had myotonic discharges. In two patients, abnormal electrical irritability was the sole EMG abnormality. Thirteen patients had abnormal nerve conduction studies consistent with polyneuropathy, but four of these patients had long-standing diabetes as well.
Histological features
In all cases, the muscle ®bres varied abnormally in size, with some ®bre diameters as small as 5 mm or as large as 150 mm. Some abnormal ®bres contained large vesicular nuclei. Seventy percent of the muscle specimens contained groups of small ®bres, with three or more small ®bres per group. In most cases, however, the atrophic ®bres accounted for only a small proportion of the total. In each case, some ®bres were subdividing by splitting, and some small ®bres arose by this mechanism. Sparse perivascular or endomysial mononuclear in¯ammatory cells appeared in <10% of the biopsy specimens. Necrotic ®bres were uncommon. Regenerating ®bres, identi®ed by cytoplasmic basophilia and vesicular nuclei with prominent nucleoli, were infrequent.
In all cases, the structurally abnormal muscle ®bres were best observed in trichrome-stained sections. Typically, these ®bres were unevenly distributed, few or none appearing in some fascicles and many present in others. The abnormal ®bres displayed one or more of the following features.
(i) Abnormal areas containing blue amorphous material. In a given ®bre, these areas were single or multiple, varied in shape and size, were super®cial or deep in position, and encompassed from a small fraction to nearly the entire extent of the cross-sectioned ®bre (Fig. 1A, E and I) .
(ii) Abnormal ®bre areas containing small (<6 mm) blue or blue±green granules. These areas varied in shape, size and position in the affected ®bres ( Fig. 1E and I) .
(iii) Spherical, lobulated or serpentine hyaline structures ( Fig. 1E and I ), blue to purple in colour and sometimes with a central red zone; these varied in size, position and abundance in the abnormal ®bres.
(iv) Typical cytoplasmic bodies were conspicuous in <10% of the specimens; a smaller proportion of the abnormal ®bres harboured nemaline rods.
(v) Some abnormal ®bres harboured small vacuoles rimmed or ®lled by membranous material. In four patients, the vacuolar change was prominent.
(vi) Some large ®bres were completely ®lled with amorphous, granular or hyaline material (Fig. 1E) .
In most specimens, the hyaline structures were congophilic. The congophilia was best observed in Congo red-stained sections viewed under rhodamine optics ( Fig. 1M and N) . The intensity of the¯uorescent signal varied from mild to very intense in the same and different specimens.
Oxidative enzyme activity was sharply reduced in ®bre regions occupied by the hyaline structures and in many other abnormal ®bre regions (Fig. 1K) . Increases of acid phosphatase were detected in some vacuoles and in small foci of many abnormal ®bres. The atrophic ®bres appearing in groups were of either histochemical type. Grouping of the histochemical ®bre types was present in 25%, and type 1 ®bre predominance in 15% of the specimens. In one-half of the cases with ®bre type grouping, the EMG revealed high-amplitude longduration MUPs. Type 2 ®bre atrophy was uncommon. Many abnormal ®bres contained small lakes of PAS-positive material. The muscle ®bre lipid content was normal.
Immunocytochemical studies Myotilin
We were interested in examining expression of myotilin in MFM because it is a recently discovered Z-disk-associated protein that cross-links actin ®laments, controls sarcomere assembly (Salmikangas et al., 2003) and binds to a-actinin and g-®lamin (van der Ven et al., 2000) . Increased myotilin expression was detected in~90% of the ®bres that were abnormal in trichrome-stained sections (Fig. 1L ).
Desmin
In all cases, desmin expression was moderately to markedly enhanced in >75% of the abnormal ®bres (Fig. 1B) . The desmin deposits were associated with amorphous and granular material and often surrounded or appeared within the hyaline structures.
aBC
The aBC deposits resembled the desmin deposits in frequency, distribution and staining intensity (Fig. 1C) .
Dystrophin
Ectopic cytoplasmic expression of dystrophin was present in close to 70% of the abnormal ®bres (Fig. 1D) .
b-APP and Ab
Increased expression of both N-and C-terminal epitopes of bAPP was observed in granular, hyaline as well as amorphous ®bre regions in close to 70% of the abnormal ®bres (Fig. 1G) . In contrast, only faint expression of Ab 42 and of the KPI domain of bAPP was detected in some ®bres in a few specimens. There was no consistent correlation between the increased expression of bAPP and the presence of the congophilic deposits in the ®bres.
NCAM
Enhanced NCAM expression was observed in 50±60% of the structurally abnormal ®bres (Fig. 1J) , in regenerating and some atrophic ®bres, and also in some structurally normal ®bres.
Filamentous actin
When monitored with rhodamine-labelled phalloidin,~50% of the abnormal ®bres showed foci of enhanced actin expression. Occasional ®bres showed circumscribed decreases of actin expression.
CDC kinase 2
CDC2 kinase (a mitotic kinase that phosphorylates and disassembles intermediate ®laments) was expressed in~40% of the abnormal ®bres, and sometimes in otherwise normal ®bres (Fig. 1F ).
Prion protein
Prion protein expression was enhanced in 60% of the abnormal ®bres (Fig. 1H) .
Plectin
Punctate or diffuse increases of plectin were observed in nonhyaline regions of 50±60% of the abnormal ®bres; the increase was mild in most ®bres and strong in a few. The hyaline structures, however, were consistently devoid of plectin.
Other proteins
Enhanced expression of a 1 -antichymotrypsin, gelsolin and ubiquitin was found in about one-third of the abnormal ®bres. In most specimens, the increase in expression of these proteins was only mild, but in a few specimens it was striking.
Ultrastructural features
In each case, the earliest ultrastructural abnormality involved the myo®bril and characteristically the Z-disk. In some ®bre regions, normal Z-disks gave rise to and were replaced by large irregular expanses of homogeneous ( Fig. 2A) or striped (Fig. 2B) dense material, or small dappled dense bodies of Zdisk intensity ( Fig. 2A and C) . Some abnormal ®bre regions also showed Z-disk streaming as well as accumulation of dappled dense bodies and myeloid structures between the myo®brils (Fig. 2C and D) .
In more advanced lesions, large ®bre areas were replaced by inclusions composed of abnormal dense material intermingled with dappled dense bodies (Fig. 3A) , or dense ®brillar material (Fig. 3B) . Both types of inclusions were surrounded by a halo of ®ne ®laments. In other ®bre regions, small electron-dense spots were intermingled with randomly oriented ®ne ®laments (Fig. 3C and D) . Still other abnormal ®bre regions were composed only of a ®lamentous network ( Fig. 4A and B) . In some cases, the degraded myo®brillar material accumulated in large spheroidal structures. Typical cytoplasmic bodies surrounded by a halo of radially arranged thin ®laments were infrequent. All these abnormal areas were devoid of mitochondria. Similar ultrastructural ®ndings were detected in patients with or without mutations in desmin or aBC.
In many ®bres, small islands of myo®brils were surrounded by degraded ®lamentous material, degenerating membranous organelles and myeloid structures (Fig. 5) . Mitochondria, other membranous organelles and glycogen accumulated in spaces vacated by myo®brils (Figs 5 and 6A) . The dislocated membranous organelles were trapped and degraded to myeloid structures in autophagic vacuoles (Fig. 6B ).
Molecular genetic studies
DNA obtained from all 63 patients was analysed for mutations in desmin, aBC, syncoilin and telethonin. Four patients carried novel missense mutations in desmin. Three of these mutations were located in the desmin head domain (S2I, S46F and S46Y) and one in the desmin tail domain (K449T) (Fig. 7) . The mutated residues, S2, S46 and K449, are conserved across mammalian species and in Xenopus.
Transfection of COS and MCF7 cells with the wild-type pEGFP-desmin construct yielded three expression patterns in both types of cells: diffuse expression in a few cells, lace-like ®laments in some cells, and coarse, thick and short ®laments in other cells. Entirely similar expression patterns were observed after transfection of COS and MCF7 cells with mutant pEGFP-desmin constructs. Thus, these expression systems yielded no insight into the pathogenic effects of the desmin mutants in vivo.
Two MFM patients carried truncation mutations in the Cterminal domain of aBC (464delCT and Q151X). Further characterization of these mutations was published separately (Selcen and Engel, 2003) . None of the mutations was detected in 200 alleles of 100 unrelated control subjects.
None of the MFM patients harboured mutations in telethonin or syncoilin.
Differences in MFM with or without identi®ed mutations in desmin or aBC
The ®ndings in muscle specimens with or without mutations in desmin or aBC were generally similar, with the following exceptions. With mutations in desmin or aBC (i) the abnormal ®bre regions were often smaller and less conspicuous; (ii) the congophilic deposits were less numerous and less intensely¯uorescent; (iii) ubiquitin expression was not enhanced; and (iv) myotilin expression was less intense and ectopic dystrophin expression more intense than in the remaining MFM patients. However, none of these morphological differences provided a basis for con®dently identifying patients with mutations in desmin or aBC.
Discussion
The morphological features of MFM differentiate it from other chronic myopathies. Although these features implicate myo®bril-and especially Z-disk-associated proteins, they do not specify the molecular aetiology. Only six of the 63 patients in the present series carried mutations in desmin or aBC. Thus, the molecular basis of 90% of MFM patients in our cohort remains undetermined.
The typical light microscopy features pointing to the diagnosis of MFM are (i) abnormal ®bre regions of varying size and shape, harbouring amorphous, granular or hyaline structures in trichrome-stained sections; (ii) sharply circumscribed decreases of oxidative enzyme activity in many abnormal ®bre regions; (iii) prominent congophilic deposits associated with hyaline structures; (iv) vacuolated muscle ®bres with membranous material within or lining the vacuoles; (v) frequent neurogenic features, and especially small groups of atrophic ®bres of either histochemical type; and (vi) abnormal and ectopic expression of multiple proteins. Not all ectopically expressed proteins appear in all Fig. 2 (A) Cones of dense material and dappled dense bodies emanate from and replace normal Z-disks. In (B), normal Z-disks are replaced by stripes of dense material and the myo®brils move out of register. In (C), widened intermyo®brillar spaces are ®lled with dappled dense bodies and some Z-disks show streaming (asterisk). In (D), the abnormal ®bre region harbours streaming Z-disks, dappled dense bodies, degenerating membranous organelles and small nemaline rods (R). Z = Z-disk. Bars = 10 mm.
structurally abnormal ®bres. The most commonly observed proteins are myotilin, desmin, aBC, bAPP and dystrophin. Therefore, immunostains for these proteins are especially useful adjuncts in the diagnosis of MFM. Previous studies of MFM have not examined myotilin expression; our observations suggest that it is the most reliable immunocytochemical marker for abnormal ®bre regions in MFM.
Electron microscopy provides further insight into the pathogenesis of MFM and suggests the following sequence of events: (i) disintegration of myo®brils that begins at the Zdisk; (ii) loss of normal myo®brillar and then of myo®bre architecture; (iii) accumulation of degraded ®lamentous material in various patterns; (iv) dislocation and aggregation of membranous organelles and glycogen in spaces vacated by myo®brils; and (v) entrapment of dislocated membranous organelles in autophagic vacuoles.
The increased aBC expression could be a response to disruption of the myo®brillar architecture and is consistent with the chaperone role of aBC for desmin and actin (Bennardini et al., 1992) . Desmin and NCAM are markers of regenerating muscle ®bres, but both of these proteins also accumulate in abnormal ®bre regions (Cashman et al., 1987; Bornemann and Schmalbruch, 1992) . Accumulation of actin, myotilin and desmin, as well as of plectin, an intermediate ®lament linker, may be compensatory to maintain Z-disk structure as all these proteins are Z-disk related and play a role in Z-disk organization (Faulkner et al., 2001; Clark et al., 2002) . The accumulation of the actin-severing protein gelsolin suggests that it participates in fragmenting the accumulated actin ®laments. CDC2 kinase phosphorylates and disassembles intermediate ®la-ments during mitosis; its inappropriate expression in MFM may result in phosphorylation of desmin and destabilization of the Z-disks (Nakano et al., 1997) . The reason for ectopic expression of dystrophin and prion protein, both membrane-associated proteins, is unclear. The ubiquitin positivity in some specimens indicates that the muscle ®bre contains undesirable material targeted for non-lysosomal degradation. However, lack of signi®cant ubiquitin positivity in most cases implies operation of an alternative pathway of protein degradation. The increased expression of the serine protease inhibitor a 1 -antichymotrypsin may be compensatory to mitigate ®bre damage by proteolytic enzymes. The intense congophilia indicates a b-pleated conformation of aggregated proteins. Electron microscopy of MFM, however, does not reveal amyloid ®laments of the type detected in systemic amyloidosis. Although expression of bAPP is enhanced, there is only mild or no expression of Ab. The chemical identity of congophilic material in MFM remains unknown. Although there are minor differences of protein expression in MFM patients with or without identi®ed mutations in desmin or aBC, these differences are not suf®cient to identify the mutation carriers. Moreover, the increased expression of any one protein does not point to an underlying mutation in a given patient, as similarly enhanced expression of desmin and aBC occurs in patients with or without mutations in these proteins. However, one can infer that the stereotyped ectopic expression of multiple proteins in MFM is the end result of a pathogenic cascade initiated when myo®brillar integrity is disrupted by different insults. Consistent with this idea is that target formations in partially denervated muscle and unstructured cores in central core disease also contain many of the abnormally expressed proteins detected in MFM lesions (De Bleecker et al., 1996b; Nakano et al., 1997) .
Desmin mutations
The observed mutations are in the head and tail domains of desmin, whereas most previously reported mutations are in the desmin rod domain that is crucial for desmin ®lament assembly (see Fig. 7 ). The pathogenic effects of the mutations observed by us could not be assessed when the genetically engineered mutants were expressed in COS cells or MCF7 cells. A likely reason for this is that the observed mutations do not hinder the assembly of desmin ®laments and that neither expression system subjects the desmin cytoskeleton to the mechanical stress of repeated contractions that occur in muscle in vivo. Consistent with our observations, the previously reported I451M mutation in the desmin tail domain also had no effect on the organization of the desmin cytoskeleton in C2.7, MCF7 and vimentin-positive or negative SW13 cells (Dalakas et al., 2003) .
Candidate genes or proteins for MFM
The MFMs genes mapped to 2q24±31 (Edstro Èm et al., 1990; Nicolao et al., 1999 ), 10q22.3 (Melberg et al., 1999 and 12q (Wilhelmsen et al., 1996) are still unidenti®ed. Other candidate genes encode proteins located or anchored at the Z-disk, or play a role in maintaining myo®brillar integrity.
Actin ®laments, the actin-associated nebulin ®laments and the thick-®lament-associated titin ®laments are anchored in the Z-disk. Within the Z-disk, telethonin caps titin, and titin has the capability of phosphorylating telethonin (Labeit et al., 1997; Sorimachi et al., 1997) . Telethonin also binds to myozenin (also known as FATZ or calsarcin) which binds to ®lamin C Takada et al., 2001; Zhou et al., 2001 ) which, in turn, is linked to myotilin (van der Ven et al., 2000) , and myotilin itself interacts with a-actinin (Hauser et al., 2000) and actin (Salmikangas et al., 2003) . Myopalladin tethers nebulin to a-actinin and probably plays a role in Z-disk assembly (Bang et al., 2001) . Cypher also binds to a-actinin and supports the Z-disk during contraction (Zhou et al., 1999 (Zhou et al., , 2001 Faulkner et al., 1999) . Myopodin colocalizes with a-actinin at the Z-disk and binds actin (Weins et al., 2001) . CapZ organizes actin ®laments during sarcomere formation and also localizes to the Z-disk (Schafer et al., 1995) . Syncoilin interacts with desmin and, together with plectin, may link desmin ®laments to the Z-disk (Newey et al., 2001; Poon et al., 2002; Howman et al, 2003) . An isoform of neuroendocrine-speci®c-protein-like-1 also colocalizes with desmin and is distributed throughout the Z-disk (Geisler et al., 1999) . Synemin (also known as desmuslin) is an intermediate ®lament that forms hybrid ®laments with desmin and has a binding site for a-actinin (Bellin et al., 1999; Mizuno et al., 2001) . The associated intermediate ®laments form a heteropolymeric lattice to organize the myo®brils at the level of the Z-disk, and to link the myo®brils to nuclei, mitochondria and the sarcolemma.
Some Z-disk-related proteins have already been implicated in inherited myopathies, e.g. mutations in actin are associated with actin myopathy and nemaline myopathy (Nowak et al., 1999) ; mutations in nebulin also result in nemaline myopathy (Pelin et al., 2002) ; telethonin mutations underlie limb-girdle muscular dystrophy (LGMD) 2G (Moreira et al., 2000) ; and myotilin mutations result in LGMD 1A (Hauser et al. 2000) . Titin mutations cause tibial muscular dystrophy (Hackman et al., 2002) , a form of LGMD (Udd et al., 1991; Haravuori et al., 2001) , or dilated cardiomyopathy (Hackman, et al., 2002) . In the nemaline and actin myopathies, the morphological alterations are unlike those in MFM, but the possibility remains that other mutations in nebulin or actin could result in an MFM phenotype. The immunocytochemical and ultrastructural features of dystrophies stemming from mutations in titin and myotilin have not been characterized extensively, and in these disorders MFM features may have gone undetected.
Further advances in de®ning the molecular causes of MFM will probably come from linkage studies of informative kinships and a search for mutations at identi®ed loci, or from systematic search for mutations in proteins participating in the intricate and interconnected network supporting the Zdisk.
